Dr. Robert Dichmann

Board Certified in Medical Oncology, Hematology and Internal Medicine, Dr. Kennedy provides compassionate care for patients at Mission Hope Cancer Center, and works collaboratively with all departments to provide patients with all aspects of cancer care. Dr. Kennedy is able to offer patients the most advanced treatment with enrollment in cutting edge clinical research studies. She has years of experience in the treatment and diagnosis of all cancers and provides her patients with individualized care for the best possible outcomes.An educator at heart, Dr. Kennedy has a passion for teaching her patients about their disease and how their treatments work. Understanding a disease is empowering for the patient and can remove some of the fear associated with a cancer diagnosis.Dr. Kennedy received her medical degree from the University of Oklahoma. She completed her Internal Medicine residency at the University of California Davis, and Hematology-Oncology fellowship program at the University of Oklahoma Health Sciences Center-Stephenson Cancer Center.As an experienced principal investigator on numerous clinical trials for cancer therapies, Dr. Kennedy has published her findings in national medical journals, and puts her research knowledge into practice when treating patients. Dr. Kennedy is highly rated in 34 conditions, according to our data. Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, Anal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.

Gregory Heestand is an Oncologist and a Hematologist Oncology provider in Templeton, California. Dr. Heestand is highly rated in 15 conditions, according to our data. His top areas of expertise are Fibrolamellar Carcinoma, Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Tissue Biopsy.

Dr. Gorgun Akpek (Dr. G) is a board certified hematologist and medical oncologist who treats his patients with all types of cancer and blood related.Dr. Akpek received his MD degree from Hacettepe University, the top medical school in Turkey and did his internal medicine residency and hematology & medical oncology clinical fellowship trainings at Hacettepe University and Boston University Medical Centers. He became further specialized in Leukemia and Stem Cell/Bone Marrow Transplantation at Johns Hopkins University Department of Oncology in Baltimore, Maryland.He joined the faculty first at Johns Hopkins University and then University of Maryland Greenebaum Cancer Center as a clinical investigator and attending physician.He continued his career as a founding Director of Leukemia and Stem Cell Transplantation/Cell Therapy programs at Banner MD Anderson Cancer Center in Gilbert, Arizona and more recently he served as the Section Chief of Blood and Marrow Transplant Program (BMT) at Rush University Medical Center in Chicago.Dr. Akpek is a member of American Society of Hematology (ASH), Clinical Oncology (ASCO) and Transplantation (ASBMT). He is nationally recognized for his research by more than 100 publications and clinical work in leukemia, lymphoma, MDS, multiple myeloma and stem cell transplantation.Board Certification:Oncology, Hematology, Internal MedicineMedical School:Hacettepe University School of MedicineInternal Medicine Residency:Hacettepe University School of MedicineFellowship Training:Hacettepe University School of Medicine, Boston University Medical Center and Johns Hopkins UniversityAreas of Interest:All Cancers including: Autoimmune Cancer, Lung Cancer, Breast Cancer, Colon Cancer, Rectal Cancer,  Pancreatic Cancer, Gallbladder Cancer, Bladder Cancer, Ovarian Cancer, MelanomaAdditional Education: Master of Public Health, Johns Hopkins Bloomberg School of Public Health 2005. Awards and Recognition: Chief's Hematology and Oncology Scholar Award, Boston University 1995-1997 Jo-Ann McCaleb Amyloid Research Award 1997 Henry Christian Award, American Federation of Medical Research 2002. Dr. Akpek is highly rated in 53 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Myelodysplastic Syndrome (MDS), Childhood Iron Deficiency Anemia, Bone Marrow Transplant, and Splenectomy.